Jeffrey L. Curtis

Active 1983–2025

157
Papers
21,750
Citations
81
h-index
150
i10-index

Citations

Citations per year for Jeffrey L. Curtis1983: 1 citations1986: 3 citations1987: 3 citations1988: 4 citations1989: 3 citations1990: 5 citations1991: 7 citations1992: 2 citations1993: 3 citations1994: 5 citations1995: 11 citations1996: 23 citations1997: 16 citations1998: 13 citations1999: 17 citations2000: 31 citations2001: 26 citations2002: 16 citations2003: 25 citations2004: 21 citations2005: 17 citations2006: 23 citations2007: 31 citations2008: 54 citations2009: 70 citations2010: 71 citations2011: 85 citations2012: 121 citations2013: 176 citations2014: 219 citations2015: 234 citations2016: 255 citations2017: 253 citations2018: 296 citations2019: 787 citations2020: 918 citations2021: 959 citations2022: 773 citations2023: 635 citations2024: 940 citations2025: 389 citations2026: 8 citations1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,470 citing papers, 26.7% of this breakdownUnited Kingdom: 876 citing papers, 9.4% of this breakdownChina: 764 citing papers, 8.2% of this breakdownCanada: 472 citing papers, 5.1% of this breakdownGermany: 398 citing papers, 4.3% of this breakdownItaly: 340 citing papers, 3.7% of this breakdownAustralia: 322 citing papers, 3.5% of this breakdownSpain: 318 citing papers, 3.4% of this breakdownNetherlands: 315 citing papers, 3.4% of this breakdownFrance: 268 citing papers, 2.9% of this breakdownJapan: 194 citing papers, 2.1% of this breakdownSweden: 183 citing papers, 2% of this breakdown
0%26.7%Other 25.3%

Fields

  • Medicine65.4%
  • Biochemistry, Genetics and Molecular Biology18.6%
  • Immunology and Microbiology6.9%
  • Environmental Science2%
  • Health Professions1.4%
  • Neuroscience1.2%
  • Other4.5%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research13.2%
  • Asthma and respiratory diseases5.5%
  • Gut microbiota and health5.4%
  • Respiratory Support and Mechanisms3.8%
  • Pediatric health and respiratory diseases3.1%
  • Respiratory and Cough-Related Research2.1%
  • Other66.9%

Coauthors

All papers

Open in search
  1. Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals

    Authors: , , , , , , , , - mBio 2015 cited by 831

  2. Bacterial Topography of the Healthy Human Lower Respiratory Tract

    Authors: , , , , , , - mBio 2017 cited by 570

  3. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene

    Authors: , , , , , , , , , , , , , - Respiratory Research 2014 cited by 390

  4. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD

    Authors: , , , , , , , , , , , - PLoS ONE 2011 cited by 959

  5. Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2013 cited by 845

  6. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 690

  7. Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography

    Authors: , , , , , , - Annals of the American Thoracic Society 2015 cited by 561

  8. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 359

  9. Azithromycin for Prevention of Exacerbations of COPD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,207

  10. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John E. Hokanson, Nan M. Laird, Christoph Lange, Sharon M. Lutz, Merry‐Lynn McDonald, Margaret M. Parker, Dandi Qiao, Elizabeth A. Regan, Stephanie A. Santorico, Edwin K. Silverman, Emily S. Wan, Sungho Won, Mustafa Al Qaisi, Harvey O. Coxson, Teresa Gray, MeiLan K. Han, Eric A. Hoffman, MeiLan K. Han, Francine L. Jacobson, Philip F. Judy, Ella A. Kazerooni, Alex Kluiber, David A. Lynch, John D. Newell, Elizabeth A. Regan, James C. Ross, Raúl San Jośe Estépar, Joyce Schroeder, Jered Sieren, Douglas R. Stinson, Berend C. Stoel, Juerg Tschirren, Edwin J.R. van Beek, Bram van Ginneken, Eva M. van Rikxoort, George R. Washko, Carla G. Wilson, Robert T. Jensen, D. H. Everett, Jim Crooks, Camille M. Moore, Matthew Strand, Carla G. Wilson, John E. Hokanson, John P. Hughes, Gregory L. Kinney, Sharon M. Lutz, Katherine Pratte, Kendra A. Young, Jeffrey L. Curtis, Kendra A. Young, Perry G. Pernicano, Nicola A. Hanania, Philip Alapat, Mustafa Atik, Venkata Bandi, Aladin M. Boriek, Kalpatha Guntupalli, Elizabeth Guy, Arun C. Nachiappan, Amit Parulekar, Dawn L. DeMeo, Craig P. Hersh, Francine L. Jacobson, George R. Washko, R. Graham Barr, John Austin, Belinda D’Souza, Gregory D. Pearson, Anna Rozenshtein and 145 more - Journal of Allergy and Clinical Immunology 2018 cited by 247

  11. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerome I. Rotter, Paul L. Auer, Alex P. Reiner, Russell P. Tracy, Debby Ngo, Robert E. Gerszten, Wanda K. O’Neal, Russell P. Bowler - PROTEOMICS 2020 cited by 185

  12. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 95

  13. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 280

  14. Clinical and Radiologic Disease in Smokers With Normal Spirometry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2015 cited by 476

  15. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 cited by 318

  16. Application of a Neutral Community Model To Assess Structuring of the Human Lung Microbiome

    Authors: , , , , , , - mBio 2015 cited by 430

  17. Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality

    Authors: , , , , , , - Annals of the American Thoracic Society 2015 cited by 215

  18. Pulmonary Arterial Enlargement and Acute Exacerbations of COPD

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 492

  19. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 cited by 317

  20. Metoprolol for the Prevention of Acute Exacerbations of COPD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeremy A. Weingarten, J. Michael Wells, Elizabeth Westfall, Stephen C. Lazarus, John E. Connett - New England Journal of Medicine 2019 cited by 178

  21. CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study

    Authors: , , , , , , , , , , , , , , , , , , , - Radiology 2018 cited by 214

  22. Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 164

  23. Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 101

  24. Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 42